New RKI-KRINKO recommendation for immunocompromised patients: Grading of immunosuppression, hospital ventilation requirements, and infection prevention in the domestic environment;Neue KRINKO-Richtlinie zu immunsupprimierten Patienten: Einteilung der Immunsuppression, lüftungstechnische Maßnahmen im Krankenhaus und Hinweise zur Infektionsprävention im häuslichen Umfeld

Umweltmedizin in Forschung und Praxis

Volumn 15, Issue 2, 2010, Pages 92-98

  Engelhart, Steffen ^a   Simon, Arne ^a   Exner, Martin ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Aspergillus fumingatus sources; Immunocompromised patients; Immunosuppression; Infection prevention; KRINKO recommendations; Ventilation and air conditioning

Indexed keywords

ASPERGILLUS;

EID: 77953066242     PISSN: 14308681     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Alwis KU, Mandryk J, Hocking AD (1999): Exposure to biohazards in wood dust: bacteria, fungi, endotoxins, and (1→ 3)-beta-D-glucans. Appl Occup Environ Hyg 14: 598-608
2. Anderson K, Morris G, Kennedy H, Croall J, Michie J, Richardson MD, Gibson B (1996): Aspergillosis in immunocompromised paediatricpatients: associations with building hygiene, design, and indoor air. Thorax 51: 256-261 (Pubitemid 26088553)
3. Arendrup MC, O'Driscoll B R, Petersen E, Denning DW (2006): Acute pulmonary aspergillosis in immunocompetent subjects after exposure to barkchippings. Scand J Infect Dis 38: 945-949 (Pubitemid 44489531)
4. Barnes RA, Rogers TR (1989): Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. J Hosp Infect 14: 89-94
5. Bille J, Marchetti O, Calandra T (2005): Changing face of health-care associated fungal infections. Curr Opin Infect Dis 18: 314-319 (Pubitemid 41017635)
6. Bodey G, Buckley M, Sathe Y, Freireich EJ (1966):Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328-340
7. Burwen DR, Lasker BA, Rao N, Durry E, Padhye AA, Jarvis WR (2001): Invasive aspergillosisoutbreakonahematology-oncology ward. Infect Control Hosp Epidemiol 22: 45-48
8. Catenacci DV, Schiller GJ (2005): Myelodysplasic syndromes: A comprehensive review. Blood Rev
9. Centers for DiseasesControl and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation (2000): Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 49:1-125, CE 121-127
10. Chanock S (1993): Evolving risk factors for infectious complications of cancertherapy. Hematol Oncol Clin North Am 7: 771-793 (Pubitemid 23226987)
11. Chanock SJ, Pizzo PA (1997): Infectious complications of patients undergoing therapy for acute leukemia: current status and future prospects. Semin Oncol 24: 132-140
12. Cornet M, Levy V, Fleury L, Lortholary J, Barquins S, Coureul MH, Deliere E, Zittoun R, Brucker G, Bouvet A (1999): Efficacy of prevention by highefficiency particulate air filtration orlaminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 20: 508-513
13. Crawford J, Dale DC, Lyman GH (2004): Chemotherapy-induced neutropenia: risks, consequences, and new directions forits management. Cancer 100: 228-237 (Pubitemid 38063629)
14. Dallorso S, Manzitti C, Dodero P, Faraci M, Rosanda C, Castagnola E (2003): Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndromeand long-lasting invasivepulmonary mycosis. Eur J Haematol 70: 322-325 (Pubitemid 36560532)
15. Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manei AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Bellanne-Chantelot C, Chomienne C (2005):Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 90: 45-53
16. Engelhart S, Hanfland J, Glasmacher A, Krizek L, Schmidt-Wolf IG, Exner M (2003): Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. J Hosp Infect 54: 300-304 (Pubitemid 37554926)
17. Ferry C, Ouachee M, LeblancT, Michel G, Notz-Carrere A.Tabrizi R, Flood T, Lutz P, Fischer A, Gluckman E, Donadieu J (2005): Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant 35: 45-50 (Pubitemid 40090055)
18. Gaur AH, Flynn PM, Shenep JL (2004): Optimummanagement of pediatric patients with fever and neutropenia. Indian J Pediatr 71: 825-835
19. Groll AH, KurzM, Schneider W, Witt V, Schmidt H, Schneider M, Schwabe D (1999): Five-year-survey of invasive aspergillosis in a paediatric cancer centre. Epidemiology, management and long-term survival. Mycoses 42: 431-442
20. Groll AH, Ritter J, Muller FM (2001): Prevention of fungal Infections in children and adolescents with cancer. Klin Padiatr 213 Suppl 1 : A50-68
21. Herbrecht R, Natarajan-Amé S, Letscher-Bru V, Canuet M (2004) Invasive Pulmonary Aspergillosis. Seminars In Respiratory And Critical Care Medicine 25: 191-202
22. Iwen PC, Davis JC, Reed EC, Winfield BA, Hinrichs SH (1994): Airborne fungal spore monitoring in a protective environment during hospital construction, and correlation with an outbreak of invasive aspergillosis. Infect Control Hosp Epidemiol 15: 303-306
23. Iwen PC, Reed EC, Armitage JO, Bierman PJ, Kessinger A, Vose JM, Arneson MA, Winfield BA, Woods GL (1993): Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Infect Control Hosp Epidemiol 14: 131-139
24. Kämpfer P, Engelhart S, Rolke M, Sennekamp J (2005): Extrinsic allergic alveolitis (hypersensitivity pneumonitis) caused by Sphingobacterium spiritivorum from the water reservoirof a steam iron. J Clin Microbiol 43: 4908-4910
25. Kates SG, McGinley KJ, Larson EL, Leyden JJ (1991): Indigenous multiresistant bacteria from flowers in hospital and nonhospital environments. Am J Infect Control 19: 156-161
26. Kontoyiannis DP, Bodey GP (2002): Invasive aspergillosis in 2002: an update. Eur J Clin Microbiol Infect Dis 21: 161-172
27. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad, II (2005): Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191: 1350-1360
28. Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad, II (2004): Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 36: 564-569
29. Kontoyiannis DP, Vaziri I, Hanna HA, Boktour M, Thornby J, Hachem R, Bodey GP, Raad, II (2001) Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin Infect Dis 33: 1676-1681 (Pubitemid 33044532)
30. Lehrnbecher T, Foster C, Vazquez N, Mackall CL, Chanock SJ (1997): Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 19: 399-417
31. LehrnbecherT, Laws H (2005) Infektionen in der pädiatrischen Hämatologie und Onkologie. Klin Padiatr
32. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U (2004): Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 18: 72-77
33. Loo VG, Bertrand C, Dixon C, Vitye D, DeSalis B, McLean AP, Brox A, Robson HG (1996):Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 17: 360-364
34. Manuel RJ, Kibbler CC (1998): The epidemiology and prevention of invasive aspergillosis. J Hosp Infect 39: 95-109
35. Marr KA, Carter RA, Boeckh M, Martin P, Corey L (2002): Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 100: 4358-4366
36. Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002): Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34: 909-917
37. Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J (2003): Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82 Suppl 2: S118-126
38. Mathys W, Klus K, Rehms H (1996): Erfahrungen mit dem Einsatz von Biotonnen mit Biofiltern hinsichtlich der Hygiene. In: Schriftenreihedes Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed): Hygieneaspekte bei der biologischen Abfallbehandlung p 215-231
39. Oberfeld G (1996): Hygieneaspekte bei der Eigenkompostierung. In: Schriftenreihe des Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed): Hygieneaspekte bei der biologischen Abfallbehandlung, p 181 -213
40. Philipp W, Haumacher R, Köhler K (1996): Keimemission aus Biotonnen in Abhängigkeit von der Abholfrequenz, dem Behältersystem und der Jahreszeit. In: Schriftenreihe des Arbeitskreises für die Nutzbarmachung von Siedlungsabfällen (ANS) e.V. (ed): Hygieneaspekte bei der biologischen Abfallbehandlung p 159-179
41. Pizzo PA, Rubin M, Freifeld A, Walsh TJ (1991 ):The child with cancerand infection. I. Empiric therapy for fever and neutropenia, and preventive strategies. J Pediatr 119: 679-694
42. Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP (2002): Masking of neutropenic patients on transportfrom hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 23:41-43
43. Reiß J (1997): Schimmelpilze. Springer, Berlin - Heidelberg - New York
44. Rhame FS, Streifel AJ, Kersey JH, Jr., McGlave PB (1984): Extrinsic risk factors for pneumonia in the patient at high risk of infection. Am J Med 76: 42-52
45. Staib F (1991 ):Molds in the masonry. Dtsch Med Wochenschr 116: 1331
46. Streifel AJ (2002): In with the good air. Infect Control Hosp Epidemiol 23: 488-490
47. Tablan OC, Anderson U, Besser R, Bridges C, Hajjeh R (2004): Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53:1-36
48. Thio CL, Smith D, Merz WG, Streifel AJ, Bova G, Gay L, Miller CB, Perl TM (2000): Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit. Infect Control Hosp Epidemiol 21: 18-23
49. Torres HA, Bodey GP, Rolston KV, Kantarjian HM, Raad, II, Kontoyiannis DP (2003): Infections in patients with aplastic anemia: experience at a tertiary care cancer center. Cancer 98: 86-93
50. Vento S, Cainelli F (2003): Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment. Lancet Oncol 4: 595-604
51. Vonberg RP, Gastmeier P (2006): Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63: 246-254